Wird geladen...

Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9

PURPOSE: Cisplatin is one of the most effective drugs for treating ovarian carcinoma (OC), which is among the most lethal types of carcinoma. However, the chemoresistance to cisplatin that develops over time leads to a poor clinical outcome for many OC patients. Therefore, it is necessary to clearly...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anal Cell Pathol (Amst)
Hauptverfasser: Kou, Xinxin, Ding, Hui, Li, Lei, Chao, Hongtu
Format: Artigo
Sprache:Inglês
Veröffentlicht: Hindawi 2021
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7929659/
https://ncbi.nlm.nih.gov/pubmed/33680718
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2021/6662486
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!